PANDOMO CC No. 1 Schwarz Noir Black Zwart

Hazard statements (CLP)

H317

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice

Hazard pictograms

GHS07

Signal word

Warning

Contains

1,2-benzisothiazol-3(2H)-one; 1,2-benzisothiazolin-3-one; 2-methylisothiazol-3(2H)-one

Hazard statements

H317 - May cause an allergic skin reaction.

Precautionary statements

P102 - Keep out of reach of children. P261 - Avoid breathing dust, fume, gas, mist, spray, vapours. P280 - Wear protective gloves, eye protection. P302+P352 - IF ON SKIN: Wash with plenty of water. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention.

Additional information

Dispose of contents/container in accordance with regional/national/international/local regulations.

PBT Substances

not relevant – no registration required

vPvB Substances

not relevant – no registration required Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH 1,2-benzisothiazol-3(2H)-one (2634-33-5)(¹), 2-methyl-2H-isothiazol-3-one (2682-20-4)(¹) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH 1,2-benzisothiazol-3(2H)-one (2634-33-5)(¹), 2-methyl-2H-isothiazol-3-one (2682-20-4)(¹) regulation, in accordance with Annex XIII (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin sensitisation, Category 1 H317 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.